Showing 5591-5600 of 19383 results for "".
U.S. Preventive Services Task Force Updates Recommendations for Depression Screening in Adults
https://reachmd.com/programs/the-jama-report/us-preventive-services-task-force-updates-recommendations-depression-screening-adults/7900/[Read the Article] Depression is a common clinical problem, and is a leading cause of disability in adults. This condition is often under recognized and under treated, affecting individuals, families, businesses and society. The U.S. Preventive Services Task Force is an independent group of medicalExamining the Mediterranean Diet’s Potential in Psoriasis Management
https://reachmd.com/programs/frontlines-psoriasis/examining-the-mediterranean-diets-potential-in-psoriasis-management/32437/Discover how the anti-inflammatory effects of the Mediterranean Diet may improve skin health and quality of life for patients with psoriasis.Venetoclax and Palbociclib in AML: Exploring New Findings
https://reachmd.com/programs/on-the-frontlines-of-amlall/venetoclax-palbociclib-aml-findings/56352/Despite recent treatment advances, most patients with acute myeloid leukemia (AML)—especially those ineligible for intensive chemotherapy—ultimately relapse due to adaptive resistance to therapies like venetoclax. Ryan Quigley is joined by Dr. Jeffrey Tyner and Dr. Melissa Stewart to exploreHarnessing AI to Predict and Prevent Schizophrenia Relapse
https://reachmd.com/programs/neurofrontiers/harnessing-ai-to-predict-and-prevent-schizophrenia-relapse/36640/Artificial intelligence is transforming how schizophrenia is monitored and managed, enabling earlier relapse detection and more personalized treatment. Tune in to hear Dr. Matcheri Keshavan explore the promise of smartphone apps, wearable sensors, and digital phenotyping as well as the critical limiSupporting Adults With DMD: A Guide to Acute and Long-Term Planning
https://reachmd.com/programs/neurofrontiers/supporting-adults-with-dmd-a-guide-to-acute-and-long-term-planning/35736/As patients with Duchenne muscular dystrophy (DMD) transition from pediatric to adult care, they may encounter healthcare professionals—from primary care to emergency medicine—without prior experience managing their condition. Explore critical gaps in adult services for DMD and gain practical insighRoflumilast Cream, 0.15%, for Atopic Dermatitis
https://reachmd.com/issues/december-2024/Roflumilast-Cream-Atopic-Dermatitis/32840/Atopic dermatitis (AD) is a chronic, persistent inflammatory condition that significantly disrupts the quality of life of patients diagnosed with it. Moreover, AD presents challenges for clinicians when counseling patients on the management of their condition. Application frequency, treatment formulAPP Biosimilar Education Video Series Module 2
https://reachmd.com/programs/crohns-colitis-foundation-perspectives/app-biosimilar-education-video-series-module-2/15967/This series is designed to give advanced practice providers a better understanding of biosimilars as treatment options and how to discuss these options with patients. In this four-module series, APPs will learn how to introduce biosimilars to their patients, discuss initiation of a biologic/biosiExplore the World with a Career in Locum Tenens
https://reachmd.com/programs/locumtenens/explore-the-world-with-a-career-in-locum-tenens/12349/Find out why an infectious disease specialist decided to extend her locum tenens stay amid the COVID-19 pandemic.Cancer Screening and Prevention: Bringing Primary Care Up to Speed
https://reachmd.com/programs/primary-care-today/cancer-screening-and-prevention-bringing-primary-care-up-to-speed/7025/Dr. Randa Sifri is an Associate Professor of the Department of Family and Community Medicine in the Sydney Kimmel Medical College at Thomas Jefferson University, Director of Reasearch in the Department, and Research Fellowship Director. Listen as Dr. Brian McDonough interviews Dr. Sifri on early diaResearch on Genetic Traits of ADHD
https://reachmd.com/programs/focus-on-neurology-and-psychiatry/research-on-genetic-traits-of-adhd/4403/Dopamine is an important neurotransmitter in the cortex, essential to movement and activity control, as well as attention and executive function, tying this transporter to ADHD. How are scientists finding the genetic markers that may be transmitted to those with ADHD, and how does this help scientis